#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2376	737.1	0	.	n	.	0	A69G	SNP	69	69	A	489	489	G	857	G	857	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2376	737.1	0	.	n	.	0	C751T	SNP	751	751	C	1171	1171	T	846	T,C	405,441	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2376	737.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1870	1870	T	941	T,C	939,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14308	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2376	737.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1604	1604	C	904	C,A	903,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24446	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4148	735.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1919	1919	A	933	A,G	932,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24446	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4148	735.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2553	2553	C	876	C,T	875,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24446	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4148	735.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2627	2627	A	822	A	822	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24446	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4148	735.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3179	3179	C	880	C,G,A	878,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	1986	folP	852	852	99.88	folP.l15.c4.ctg.1	1921	128.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	980	982	AAA	191;190;187	A;A;A	191;190;187	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	1986	folP	852	852	99.88	folP.l15.c4.ctg.1	1921	128.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1211	1213	AGC	186;188;189	A;G;C,G	186;188;188,1	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4908	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3755	162.7	1	SNP	p	S91F	0	.	.	271	273	TCC	798	800	TCC	198;198;197	T,A;C;C	197,1;198;197	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4908	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3755	162.7	1	SNP	p	D95N	0	.	.	283	285	GAC	810	812	GAC	203;202;203	G;A;C	203;202;203	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4908	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3755	162.7	1	SNP	p	D95G	0	.	.	283	285	GAC	810	812	GAC	203;202;203	G;A;C	203;202;203	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1974	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1546	156.8	1	SNP	p	G45D	0	.	.	133	135	GGC	599	601	GGC	237;238;236	G,A;G;C	236,1;238;236	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1090	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1600	85.1	0	.	n	.	0	A197.	DEL	197	197	A	889	889	A	227	A,T,C	225,1,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4720	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3513	167.8	1	SNP	p	D86N	0	.	.	256	258	GAC	869	871	GAC	186;187;185	G;A;C,T	186;187;184,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4720	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3513	167.8	1	SNP	p	S87W	0	.	.	259	261	AGT	872	874	AGT	183;183;182	A;G;T,C	183;183;181,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4720	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3513	167.8	1	SNP	p	S87I	0	.	.	259	261	AGT	872	874	AGT	183;183;182	A;G;T,C	183;183;181,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4720	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3513	167.8	1	SNP	p	S87R	0	.	.	259	261	AGT	872	874	AGT	183;183;182	A;G;T,C	183;183;181,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4720	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3513	167.8	1	SNP	p	S88P	0	.	.	262	264	TCC	875	877	TCC	182;184;181	T,A;C;C	181,1;184;181	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4016	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3335	150.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1877	1879	GGC	207;206;204	G;G;C	207;206;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1549	1551	GCA	209;211;210	G;C;A	209;211;210	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1552	1554	ATC	208;211;212	A;T,C,A;C	208;209,1,1;212	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1564	1566	GTG	217;217;217	G;T;G,A	217;217;216,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1564	1566	GTG	217;217;217	G;T;G,A	217;217;216,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2068	2070	ACC	217;220;220	A;C,G;C	217;219,1;220	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2122	2124	GCG	223;223;224	G,C;C;G	221,1;223;224	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2122	2124	GCG	223;223;224	G,C;C;G	221,1;223;224	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2245	2247	GGC	229;229;228	G;G;C	229;229;228	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2254	2256	GGC	218;218;218	G;G;C	218;218;218	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3802	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	162.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2272	2274	CTG	211;210;212	C,A;T,G,C;G	210,1;208,1,1;212	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5202	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3616	179.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1833	1835	CCG	202;203;204	C;C,A;G	202;202,1;204	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2182	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2291	118.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	818	818	C	161	C,G	160,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	292	porB1a	984	100	94.0	porB1a.l15.c17.ctg.2	182	51.5	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	60;58;55	A;C;G	60;58;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	292	porB1a	984	100	94.0	porB1a.l15.c17.ctg.2	182	51.5	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	15;14;9	C;A;A	15;14;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	292	porB1a	984	156	92.95	porB1a.l15.c17.ctg.5	156	48.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	32;34;34	T;T;A	32;34;34	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	292	porB1a	984	156	92.95	porB1a.l15.c17.ctg.5	156	48.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	60;60;60	C;A;T	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	292	porB1a	984	156	92.95	porB1a.l15.c17.ctg.5	156	48.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	60;60;60	A;G;T	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	292	porB1a	984	156	92.95	porB1a.l15.c17.ctg.5	156	48.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	60;60;60	T;A;C	60;60;60	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	540	542	GAA	289;287;283	G,C;A,C;A	288,1;286,1;283	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	828	830	GAT	262;260;259	G,T;A;T,G	260,1;260;258,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	951	953	TCA	283;283;285	T;C,T;A	283;282,1;285	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1080	1082	GTC	271;272;272	G;T;C	271;272;272	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1410	1412	GCA	234;236;239	G;C;A	234;236;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	1	SNP	p	G120K	1	.	.	358	360	AAG	786	788	AAG	259;258;262	A,T,G;A,G;G	257,1,1;257,1;262	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	1	SNP	p	D121N	0	.	.	361	363	GAC	789	791	GAC	264;271;271	G;A;C	264;271;271	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3208	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	2129	186.9	1	SNP	p	A121D	1	.	.	361	363	GAC	789	791	GAC	264;271;271	G;A;C	264;271;271	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10082	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5337	235.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2266	2268	AAT	248;247;250	A;A;T	248;247;250	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1498	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1542	121.1	1	SNP	p	V57M	1	.	.	169	171	ATG	829	831	ATG	278;280;279	A;T,G;G,C	278;279,1;278,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
